Skip Navigation



Rheumatology Advance Access published online on January 5, 2005
Rheumatology, doi:10.1093/rheumatology/keh464
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
44/2/157    most recent
keh464v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Ledingham, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ledingham, J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

British Society for Rheumatology; all rights reserved
Received August 20, 2004
Accepted October 5, 2004

Guidelines

Update on the British Society for Rheumatology guidelines for prescribing TNF{alpha} blockers in adults with rheumatoid arthritis (update of previous guidelines of April 2001)

J. Ledingham 1, C. Deighton 2*, and on behalf of the British Society for Rheumatology Standards, Guidelines and Audit Working Group (SGAWG)

1 Queen Alexandra Hospital, Portsmouth, UK
2 Southern Derbyshire Acute Hospitals NHS Trust, UK

* To whom correspondence should be addressed.
C. Deighton, E-mail: chris.deighton{at}derbyhospitals.nhs.uk



This article has no Abstract.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Rheumatology (Oxford)Home page
K. L. Hyrich, C. Deighton, K. D. Watson, BSRBR Control Centre Consortium, D. P. M. Symmons, M. Lunt, and on behalf of the British Society for Rheumatology
Benefit of anti-TNF therapy in rheumatoid arthritis patients with moderate disease activity
Rheumatology, October 1, 2009; 48(10): 1323 - 1327.
[Abstract] [Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
E. L. Williams, S. Gadola, and C. J. Edwards
Anti-TNF-induced lupus
Rheumatology, July 1, 2009; 48(7): 716 - 720.
[Abstract] [Full Text] [PDF]

Home page
 The Journal of RheumatologyHome page
T. KOIKE, M. HARIGAI, S. INOKUMA, K. INOUE, N. ISHIGURO, J. RYU, T. TAKEUCHI, Y. TANAKA, H. YAMANAKA, K. FUJII, et al.
Postmarketing Surveillance of the Safety and Effectiveness of Etanercept in Japan
J Rheumatol, May 1, 2009; 36(5): 898 - 906.
[Abstract] [Full Text] [PDF]

Home page
 Ann Rheum DisHome page
M J Harrison, W G Dixon, K D Watson, Y King, R Groves, K L Hyrich, D P M Symmons, and the British Society for Rheumatology Biologics, and on behalf of the BSRBR
Rates of new-onset psoriasis in patients with rheumatoid arthritis receiving anti-tumour necrosis factor {alpha} therapy: results from the British Society for Rheumatology Biologics Register
Ann Rheum Dis, February 1, 2009; 68(2): 209 - 215.
[Abstract] [Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
C. Deighton and K. Hyrich
Why do the French get much greater access to anti-TNF than the British? Vive la difference? Pas necessairement
Rheumatology, November 1, 2008; 47(11): 1600 - 1602.
[Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
B. Fautrel, R. M. Flipo, and A. Saraux
Eligibility of rheumatoid arthritis patients for anti-TNF-{alpha} therapy according to the 2005 recommendations of the French and British Societies for Rheumatology
Rheumatology, November 1, 2008; 47(11): 1698 - 1703.
[Abstract] [Full Text] [PDF]

Home page
 Ann Rheum DisHome page
A Kavanaugh, L Klareskog, D van der Heijde, J Li, B Freundlich, and M Hooper
Improvements in clinical response between 12 and 24 weeks in patients with rheumatoid arthritis on etanercept therapy with or without methotrexate
Ann Rheum Dis, October 1, 2008; 67(10): 1444 - 1447.
[Abstract] [Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
K. L. Hyrich, K. D. Watson, D. A. Isenberg, D. P. M. Symmons, and on behalf of the BSR Biologics Register
The British Society for Rheumatology Biologics Register: 6 years on
Rheumatology, October 1, 2008; 47(10): 1441 - 1443.
[Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
N. Smith, T. Ding, S. Butt, K. Gadsby, and C. Deighton
The importance of the baseline Disease Activity Score 28 in determining responders and non-responders to anti-TNF in UK clinical practice
Rheumatology, September 1, 2008; 47(9): 1389 - 1391.
[Abstract] [Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
J. M. Pocock, J. C. Vasconcelos, and A. J. K. Ostor
Assessment of anti-TNF-{alpha} efficacy in rheumatoid arthritis: is 3 months sufficient?
Rheumatology, July 1, 2008; 47(7): 1073 - 1076.
[Abstract] [Full Text] [PDF]

Home page
 Ann Rheum DisHome page
E H S Choy, C M Smith, V Farewell, D Walker, A Hassell, L Chau, D L Scott, and for the CARDERA (Combination Anti-Rheumatic Drugs
Factorial randomised controlled trial of glucocorticoids and combination disease modifying drugs in early rheumatoid arthritis
Ann Rheum Dis, May 1, 2008; 67(5): 656 - 663.
[Abstract] [Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
G. S. Metsios, A. Stavropoulos-Kalinoglou, V. F. Panoulas, Y. Koutedakis, A. M. Nevill, K. M. J. Douglas, M. Kita, and G. D. Kitas
New resting energy expenditure prediction equations for patients with rheumatoid arthritis
Rheumatology, April 1, 2008; 47(4): 500 - 506.
[Abstract] [Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
W. J. Taylor, A. A. Harrison, J. Highton, P. Chapman, L. Stamp, J. Dockerty, F. McQueen, P. B. B. Jones, D. Ching, D. Porter, et al.
Disease Activity Score 28-ESR bears a similar relationship to treatment decisions across different rheumatologists, but misclassification is too frequent to replace physician judgement
Rheumatology, April 1, 2008; 47(4): 514 - 518.
[Abstract] [Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
C. Wenham, K. Gadsby, and C. Deighton
Three significant cases of neutropenia with etanercept
Rheumatology, March 1, 2008; 47(3): 376 - 377.
[Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
S. Jerram, S. Butt, K. Gadsby, and C. Deighton
Discrepancies between the EULAR response criteria and the NICE guidelines for continuation of anti-TNF therapy in RA: a cause for concern?
Rheumatology, February 1, 2008; 47(2): 180 - 182.
[Abstract] [Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
A. Bharadwaj, S. Agrawal, M. Batley, and A. Hammond
Use of parenteral methotrexate significantly reduces the need for biological therapy
Rheumatology, February 1, 2008; 47(2): 222 - 222.
[Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
N. Smith, K. Gadsby, S. Butt, D. Carruthers, A. Deeming, J. Ledingham, M. Fletcher, D. Mulherin, S. Roskell, L. Kay, et al.
Is pre-assessment for anti-TNF therapy in RA necessary in the UK? Analysis of DAS28 in six centres
Rheumatology, October 1, 2007; 46(10): 1557 - 1559.
[Abstract] [Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
M. C. Greenwood, J. Rathi, A. J. Hakim, D. L. Scott, and D. V. Doyle
Regression to the mean using the disease activity score in eligibility and response criteria for prescribing TNF-{alpha} inhibitors in adults with rheumatoid arthritis
Rheumatology, July 1, 2007; 46(7): 1165 - 1167.
[Abstract] [Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
J. G. Jones
The rehabilitation model rules in RA until biomedicine transforms tomorrow's rheumatologist into a real thaumaturgus
Rheumatology, May 1, 2007; 46(5): 890 - 891.
[Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
K. Gadsby and C. Deighton
Characteristics and treatment responses of patients satisfying the BSR guidelines for anti-TNF in ankylosing spondylitis
Rheumatology, March 1, 2007; 46(3): 439 - 441.
[Abstract] [Full Text] [PDF]

Home page
 Ann Rheum DisHome page
S Rajakulendran, K Gadsby, D Allen, S O'Reilly, and C Deighton
Neutropenia while receiving anti-tumour necrosis factor treatment for rheumatoid arthritis.
Ann Rheum Dis, December 1, 2006; 65(12): 1678 - 1679.
[Full Text] [PDF]

Home page
 DTBHome page
Combination therapy for early rheumatoid arthritis
DTB, November 1, 2006; 44(11): 81 - 85.
[Abstract] [Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
C. Deighton and J. Ledingham
An error in the revised anti-TNF therapy guidelines for adult RA
Rheumatology, September 1, 2006; 45(9): 1170 - 1170.
[Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
R. Luqmani, S. Hennell, C. Estrach, F. Birrell, A. Bosworth, G. Davenport, C. Fokke, N. Goodson, P. Jeffreson, E. Lamb, et al.
British Society for Rheumatology and British Health Professionals in Rheumatology Guideline for the Management of Rheumatoid Arthritis (the first two years)
Rheumatology, September 1, 2006; 45(9): 1167 - 1169.
[Full Text] [PDF]

Home page
 J Hand Surg Eur VolHome page
A. Jain, O Harley, R. M. Patel, and J. Nanchahal
Survey on the Perioperative Use of TNF{alpha} Inhibitors in Rheumatoid Hand Surgery
J Hand Surg Eur Vol., August 1, 2006; 31(4): 463 - 464.
[Full Text] [PDF]

Home page
 Postgrad. Med. J.Home page
S J Bourke
Interstitial lung disease: progress and problems.
Postgrad. Med. J., August 1, 2006; 82(970): 494 - 499.
[Abstract] [Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
V. Saravanan and C. Kelly
Drug-related pulmonary problems in patients with rheumatoid arthritis
Rheumatology, July 1, 2006; 45(7): 787 - 789.
[Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
C. M. Deighton, E. George, P. D. W. Kiely, J. Ledingham, R. A. Luqmani, and D. G. I. Scott
Updating the British Society for Rheumatology guidelines for anti-tumour necrosis factor therapy in adult rheumatoid arthritis (again)
Rheumatology, June 1, 2006; 45(6): 649 - 652.
[Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
C. Deighton and J. Ledingham
The updated BSR Guidelines for anti-TNF in adult RA: advice on septic arthroplasties: reply
Rheumatology, August 1, 2005; 44(8): 1075 - 1076.
[Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
M. Fernandez-Castro, J. L. Andreu, P. Munoz, and L. Silva
Sepsis of a prosthetic joint and biological therapies
Rheumatology, August 1, 2005; 44(8): 1076 - 1077.
[Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
A. Keat, N. Barkham, A. Bhalla, K. Gaffney, H. Marzo-Ortega, S. Paul, F. Rogers, M. Somerville, R. Sturrock, P. Wordsworth, et al.
BSR guidelines for prescribing TNF-{alpha} blockers in adults with ankylosing spondylitis. Report of a working party of the British Society for Rheumatology
Rheumatology, July 1, 2005; 44(7): 939 - 947.
[Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
J. Keane
TNF-blocking agents and tuberculosis: new drugs illuminate an old topic
Rheumatology, June 1, 2005; 44(6): 714 - 720.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.